BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2549 related articles for article (PubMed ID: 12828109)

  • 1. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of the role of surgery in the multimodal treatment of MALT gastric lymphomas.
    Kelessis NG; Vassilopoulos PP; Bai MP; Agnantis NJ; Avital SR; Rosenthal RJ
    Anticancer Res; 2002; 22(6B):3457-63. PubMed ID: 12552939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of stage 1 gastric cancer: comparison of macroscopic and microscopic findings.
    Baba H; Ohshiro T; Yamamoto M; Endo K; Adachi E; Kakeji Y; Kohnoe S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):554-8. PubMed ID: 9164536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after curative resection for stage IE and IIE primary gastric lymphoma.
    Bozer M; Eroglu A; Unal E; Eryavuz Y; Kocaoglu H; Demirci S
    Hepatogastroenterology; 2001; 48(40):1202-5. PubMed ID: 11490834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
    Jezersek Novaković B; Vovk M; Juznic Setina T
    Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical therapy of non-Hodgkin lymphoma of the stomach].
    Zippel K; Agnes A; Zieren HU
    Zentralbl Chir; 1998; 123(1):53-7. PubMed ID: 9542031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
    Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
    Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of gastric tumours in our practice: a five year survey].
    Ondrejka P; Bereczky B; Ráth Z; István G; Forgács B; Sugár I
    Zentralbl Chir; 2004 Apr; 129(2):122-4. PubMed ID: 15106044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Our experience in Helicobacter pylori infection and gastric MALToma.
    Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
    Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of surgery, its results and complications, in the combined treatment of primary gastric non-Hodgkin lymphoma].
    Szúcs G; Tóth I; Barna T; Nagy Z; Horváth G; Kiss JI
    Magy Seb; 2000 Dec; 53(6):253-8. PubMed ID: 11299490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study.
    Radman I; Kovacević-Metelko J; Aurer I; Nemet D; Zupancić-Salek S; Bogdanić V; Sertić D; Mrsić M; Pulanić R; Gasparović V; Labar B
    Croat Med J; 2002 Oct; 43(5):555-60. PubMed ID: 12402395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 128.